Որոնման արդյունքները - Nicola, Mozzillo
- Ցուցադրվում են 1 - 20 արդյունքները 26
- Գնացեք Հաջորդ էջ
-
1
-
2
Sequencing of BRAF inhibitors and ipilimumab in patients with metastatic melanoma: a possible algorithm for clinical use Paolo A. Ascierto, Ester Simeone, Diana Giannarelli, Antonio M. Grimaldi, Anna Virgínia Calazans Romano, Nicola Mozzillo
Հրապարակվել է 2012Artigo -
3
-
4
Long-lasting response to electrochemotherapy in melanoma patients with cutaneous metastasis Corrado Caracò, Nicola Mozzillo, Ugo Marone, Ester Simeone, Lucia Benedetto, Gianluca Di Monta, Maria Luisa Di Cecilia, Gerardo Botti, Paolo A. Ascierto
Հրապարակվել է 2013Artigo -
5
-
6
The role of BRAF V600 mutation in melanoma Paolo A. Ascierto, John M. Kirkwood, Jean‐Jacques Grob, Ester Simeone, Antonio M. Grimaldi, Michele Maio, Giuseppe Palmieri, Alessandro Testori, Francesco M. Marincola, Nicola Mozzillo
Հրապարակվել է 2012Editorial -
7
Correlation between immune-related adverse events and response to pembrolizumab in advanced melanoma patients Antonio M. Grimaldi, Ester Simeone, Lucia Festino, Diana Giannarelli, Marco Palla, Corrado Caracò, Marcello Curvietto, Assunta Esposito, Maria Grazia Grimaldi, Nicola Mozzillo, Paolo A. Ascierto
Հրապարակվել է 2015Artigo -
8
Electrochemotherapy efficacy evaluation for treatment of locally advanced stage III cutaneous squamous cell carcinoma: a 22-cases retrospective analysis Gianluca Di Monta, Corrado Caracò, Ester Simeone, Antonio M. Grimaldi, Ugo Marone, Massimiliano Di Marzo, Vito Vanella, Lucia Festino, Marco Palla, Stefano Mori, Nicola Mozzillo, Paolo A. Ascierto
Հրապարակվել է 2017Artigo -
9
AurkA inhibitors enhance the effects of B-RAF and MEK inhibitors in melanoma treatment Emilia Caputo, Roberta Miceli, Maria Letizia Motti, Rosarita Tatè, Federica Fratangelo, Gerardo Botti, Nicola Mozzillo, Maria Vincenza Carriero, Ernesta Cavalcanti, Giuseppe Palmieri, Gennaro Ciliberto, Giuseppe Pirozzi, Paolo A. Ascierto
Հրապարակվել է 2014Artigo -
10
Assessment of Prognostic Circulating Tumor Cells in a Phase III Trial of Adjuvant Immunotherapy After Complete Resection of Stage IV Melanoma Sojun Hoshimoto, Mark B. Faries, Donald L. Morton, Tatsushi Shingai, Christine Kuo, He Jing Wang, Robert M. Elashoff, Nicola Mozzillo, Mark C. Kelley, John F. Thompson, Jeffrey E. Lee, Dave S.�B. Hoon
Հրապարակվել է 2011Artigo -
11
Nonsentinel Lymph Node Status in Patients With Cutaneous Melanoma: Results From a Multi-Institution Prognostic Study Sandro Pasquali, Simone Mocellin, Nicola Mozzillo, Andrea Maurichi, Pietro Quaglino, Lorenzo Borgognoni, Nicola Solari, Dario Piazzalunga, L. Mascheroni, Giuseppe Giudice, Roberto Patuzzo, Corrado Caracò, Simone Ribero, Ugo Marone, Mario Santinami, Carlo Riccardo Rossi
Հրապարակվել է 2014Artigo -
12
Validation of the Accuracy of Intraoperative Lymphatic Mapping and Sentinel Lymphadenectomy for Early-Stage Melanoma Donald L. Morton, John F. Thompson, Richard Essner, Robert M. Elashoff, Stacey L. Stern, Omgo E. Nieweg, Daniel F. Roses, Constantine P. Karakousis, Nicola Mozzillo, Douglas S. Reintgen, He-Jing Wang, M Edwin, Carolyn Glass, Alistair J. Cochran
Հրապարակվել է 1999Artigo -
13
Abscopal effects of radiotherapy on advanced melanoma patients who progressed after ipilimumab immunotherapy Antonio M. Grimaldi, Ester Simeone, Diana Giannarelli, Paolo Muto, Sara Falivene, Valentina Borzillo, F Giugliano, Fabio Sandomenico, Antonella Petrillo, Marcello Curvietto, Assunta Esposito, Miriam Paone, Marco Palla, Giuseppe Palmieri, Corrado Caracò, Gennaro Ciliberto, Nicola Mozzillo, Paolo A. Ascierto
Հրապարակվել է 2014Artigo -
14
Sentinel Node Biopsy for Early-Stage Melanoma Donald L. Morton, Alistair J. Cochran, John F. Thompson, Robert M. Elashoff, Richard Essner, Edwin C. Glass, Nicola Mozzillo, Omgo E. Nieweg, Daniel F. Roses, Harald J. Hoekstra, Constantine P. Karakousis, Douglas S. Reintgen, Brendon J. Coventry, Hong Wang
Հրապարակվել է 2005Artigo -
15
Treatment efficacy with electrochemotherapy: A multi-institutional prospective observational study on 376 patients with superficial tumors L Campana, Alessandro Testori, Paolo Curatolo, Pietro Quaglino, Simone Mocellin, Massimo Framarini, Lorenzo Borgognoni, Paolo A. Ascierto, Nicola Mozzillo, Michele Guida, S. Bucher, Roberta Rotunno, Federica Marenco, Gian Luca De Salvo, Angela De Paoli, Carlo Riccardo Rossi, A Bonadies
Հրապարակվել է 2016Artigo -
16
Sentinel-Node Biopsy or Nodal Observation in Melanoma Donald L. Morton, John F. Thompson, Alistair J. Cochran, Nicola Mozzillo, Robert M. Elashoff, Richard Essner, Omgo E. Nieweg, Daniel F. Roses, Harald J. Hoekstra, Constantine P. Karakousis, Douglas S. Reintgen, Brendon J. Coventry, Edwin C. Glass, He-Jing Wang
Հրապարակվել է 2006Artigo -
17
Assessing a novel immuno-oncology-based combination therapy: Ipilimumab plus electrochemotherapy Nicola Mozzillo, Ester Simeone, Lucia Benedetto, Marcello Curvietto, Diana Giannarelli, Giusy Gentilcore, Rosa Camerlingo, Mariaelena Capone, Gabriele Madonna, Lucia Festino, Corrado Caracò, Gianluca Di Monta, Ugo Marone, Massimiliano Di Marzo, Antonio M. Grimaldi, Stefano Mori, Gennaro Ciliberto, Paolo A. Ascierto
Հրապարակվել է 2015Artigo -
18
The Impact on Morbidity and Length of Stay of Early Versus Delayed Complete Lymphadenectomy in Melanoma: Results of the Multicenter Selective Lymphadenectomy Trial (I) Mark B. Faries, John F. Thompson, Alistair J. Cochran, Robert M. Elashoff, Edwin C. Glass, Nicola Mozzillo, Omgo E. Nieweg, Daniel F. Roses, H.J. Hoekstra, Constantine P. Karakousis, Douglas S. Reintgen, Brendon J. Coventry, He-Jing Wang, Donald L. Morton
Հրապարակվել է 2010Artigo -
19
<i>BRAF/NRAS</i> Mutation Frequencies Among Primary Tumors and Metastases in Patients With Melanoma Maria Colombino, Mariaelena Capone, Amelia Lissia, Antonio Cossu, Corrado Rubino, Vincenzo De Giorgi, Daniela Massi, Ester Fonsatti, Stefania Staibano, Oscar Nappi, Elena Pagani, Milena Casula, Antonella Manca, Maria Cristina Sini, Renato Franco, Gerardo Botti, Corrado Caracò, Nicola Mozzillo, Paolo A. Ascierto, Giuseppe Palmieri
Հրապարակվել է 2012Artigo -
20
Immunological and biological changes during ipilimumab treatment and their potential correlation with clinical response and survival in patients with advanced melanoma Ester Simeone, Giusy Gentilcore, Diana Giannarelli, Antonio M. Grimaldi, Corrado Caracò, Marcello Curvietto, Assunta Esposito, Miriam Paone, Marco Palla, Ernesta Cavalcanti, Fabio Sandomenico, Antonella Petrillo, Gerardo Botti, Franco Fulciniti, Giuseppe Palmieri, Paola Queirolo, Paolo Marchetti, Virginia Ferraresi, Gaetana Rinaldi, Maria Pia Pistillo, Gennaro Ciliberto, Nicola Mozzillo, Paolo A. Ascierto
Հրապարակվել է 2014Artigo
Որոնման գործիքներ:
Առնչվող խորագիր
Medicine
Cancer research
Melanoma
Internal medicine
Cancer
Oncology
Biology
Surgery
Immunotherapy
Ipilimumab
Biochemistry
Breast cancer
Immunology
Lymph node
Lymphadenectomy
MAPK/ERK pathway
Metastatic melanoma
Paleontology
Radiology
Sentinel node
Stage (stratigraphy)
Adverse effect
Biopsy
Bleomycin
Cell biology
Chemotherapy
Clinical trial
Confidence interval
Electrochemotherapy
Gene